Zymergen Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Zymergen Inc. | ZY - NASDAQ |
$28.00-$31.00 | $31.00 | $40.30 | 16.1 million | 4/22/2021 |
| JP Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank, Lazard | ||||||
Co-Manager(s): | ||||||
| Materials | ||||||
Filing(s): Filed 2021-03-23 Terms Added 2021-04-13 | ||||||
Zymergen Inc. Quote & Chart - Click for current quote - ZY
IPO Boutique aggregates information on public companies and private companies, such as "ZY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Zymergen Inc. (adapted from Zymergen Inc. prospectus):
They partner with Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They partner with Nature to design, develop, and commercialize bio-based breakthrough products that deliver extraordinary value to customers in a broad range of industries.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "ZY" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.